Chris Nolet is a director of Jasper Therapeutics Inc.
Person profile
Roles
Address
Newark, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ArriVent Biopharma, Inc.
29 Jan 24
3
ArriVent Biopharma, Inc.
25 Jan 24
4
Jasper Therapeutics, Inc.
8 Jun 23
4
Revance Therapeutics, Inc.
5 May 23
4
POLARITYTE, INC.
17 Jan 23
4
Jasper Therapeutics, Inc.
13 Oct 22
4
POLARITYTE, INC.
4 Oct 22
4/A
Revance Therapeutics, Inc.
13 May 22
4
Revance Therapeutics, Inc.
6 May 22
4
Jasper Therapeutics, Inc.
23 Mar 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Jan 24 | AVBP ArriVent BioPharma | Stock Option Common Stock | Grant | Acquire A | No | No | 18 | 17,884 | 321.91 k | 17,884 |
7 Jun 23 | JSPR Jasper Therapeutics | Stock Option Voting Common Stock | Grant | Acquire A | No | No | 1.6 | 47,000 | 75.20 k | 47,000 |
3 May 23 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 3,534 | 0.00 | 28,606 |
3 May 23 | RVNC Revance Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 33.61 | 5,915 | 198.80 k | 5,915 |
12 Jan 23 | RGTPQ Polarityte | Common Stock | Option exercise | Dispose M | No | No | 0 | 36,497 | 0.00 | 14,403 |
12 Jan 23 | RGTPQ Polarityte | Stock option Common Stock | Option exercise | Dispose M | No | No | 22.5 | 3,078 | 69.26 k | 6,157 |